Global Onychomycosis (Tinea Unguium) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 101

Published Date: 04 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Onychomycosis (Tinea Unguium) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Onychomycosis (Tinea Unguium) Drug size is estimated to be USD 3962.6 million in 2026 from USD 3194.9 million in 2020, with a change XX% between 2020 and 2021. The global Onychomycosis (Tinea Unguium) Drug market size is expected to grow at a CAGR of 5.5% for the next five years.

Market segmentation
Onychomycosis (Tinea Unguium) Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral Medication
    External Medicine

Market segment by Application, can be divided into
    Age under 18
    Age 18-50
    Age above 50

Market segment by players, this report covers
    Pfizer
    Yangtze River
    Torrent Pharma
    J&J
    Chengdu Brilliant
    Novartis
    Qilu Pharmaceutical
    Xiuzheng Pharmaceutical
    Hubei Hengan
    TARO
    Perrigo
    Galderma pharm
    Zhejiang Deyer
    Valeant Pharma
    Moberg

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Onychomycosis (Tinea Unguium) Drug, with revenue, gross margin and global market share of Onychomycosis (Tinea Unguium) Drug from 2019 to 2021.
Chapter 3, the Onychomycosis (Tinea Unguium) Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Onychomycosis (Tinea Unguium) Drug research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
    1.2 Classification of Onychomycosis (Tinea Unguium) Drug by Type
        1.2.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type in 2020
        1.2.3 Oral Medication
        1.2.4 External Medicine
    1.3 Global Onychomycosis (Tinea Unguium) Drug Market by Application
        1.3.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Age under 18
        1.3.3 Age 18-50
        1.3.4 Age above 50
    1.4 Global Onychomycosis (Tinea Unguium) Drug Market Size & Forecast
    1.5 Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Region
        1.5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region, (2016-2021)
        1.5.3 North America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.6 South America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Onychomycosis (Tinea Unguium) Drug Market Drivers
        1.6.2 Onychomycosis (Tinea Unguium) Drug Market Restraints
        1.6.3 Onychomycosis (Tinea Unguium) Drug Trends Analysis

2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.1.4 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Yangtze River
        2.2.1 Yangtze River Details
        2.2.2 Yangtze River Major Business
        2.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.2.4 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Yangtze River Recent Developments and Future Plans
    2.3 Torrent Pharma
        2.3.1 Torrent Pharma Details
        2.3.2 Torrent Pharma Major Business
        2.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Torrent Pharma Recent Developments and Future Plans
    2.4 J&J
        2.4.1 J&J Details
        2.4.2 J&J Major Business
        2.4.3 J&J Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.4.4 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 J&J Recent Developments and Future Plans
    2.5 Chengdu Brilliant
        2.5.1 Chengdu Brilliant Details
        2.5.2 Chengdu Brilliant Major Business
        2.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.5.4 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Chengdu Brilliant Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.6.4 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Qilu Pharmaceutical
        2.7.1 Qilu Pharmaceutical Details
        2.7.2 Qilu Pharmaceutical Major Business
        2.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.7.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Qilu Pharmaceutical Recent Developments and Future Plans
    2.8 Xiuzheng Pharmaceutical
        2.8.1 Xiuzheng Pharmaceutical Details
        2.8.2 Xiuzheng Pharmaceutical Major Business
        2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Xiuzheng Pharmaceutical Recent Developments and Future Plans
    2.9 Hubei Hengan
        2.9.1 Hubei Hengan Details
        2.9.2 Hubei Hengan Major Business
        2.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.9.4 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Hubei Hengan Recent Developments and Future Plans
    2.10 TARO
        2.10.1 TARO Details
        2.10.2 TARO Major Business
        2.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.10.4 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 TARO Recent Developments and Future Plans
    2.11 Perrigo
        2.11.1 Perrigo Details
        2.11.2 Perrigo Major Business
        2.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.11.4 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Perrigo Recent Developments and Future Plans
    2.12 Galderma pharm
        2.12.1 Galderma pharm Details
        2.12.2 Galderma pharm Major Business
        2.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.12.4 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Galderma pharm Recent Developments and Future Plans
    2.13 Zhejiang Deyer
        2.13.1 Zhejiang Deyer Details
        2.13.2 Zhejiang Deyer Major Business
        2.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.13.4 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Zhejiang Deyer Recent Developments and Future Plans
    2.14 Valeant Pharma
        2.14.1 Valeant Pharma Details
        2.14.2 Valeant Pharma Major Business
        2.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.14.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Valeant Pharma Recent Developments and Future Plans
    2.15 Moberg
        2.15.1 Moberg Details
        2.15.2 Moberg Major Business
        2.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.15.4 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Moberg Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Onychomycosis (Tinea Unguium) Drug Players Market Share
        3.2.2 Top 10 Onychomycosis (Tinea Unguium) Drug Players Market Share
        3.2.3 Market Competition Trend
    3.3 Onychomycosis (Tinea Unguium) Drug Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2016-2021)
    4.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2021)
    5.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    6.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
        6.3.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        6.3.2 United States Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        6.3.3 Canada Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        6.3.4 Mexico Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    7.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
        7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        7.3.2 Germany Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.3 France Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.5 Russia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.6 Italy Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    8.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
        8.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2026)
        8.3.2 China Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.3 Japan Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.4 South Korea Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.5 India Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.7 Australia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    9.2 South America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    9.3 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country
        9.3.1 South America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        9.3.2 Brazil Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        9.3.3 Argentina Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    10.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    10.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
        10.3.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        10.3.2 Turkey Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        10.3.4 UAE Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Onychomycosis (Tinea Unguium) Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Onychomycosis (Tinea Unguium) Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2021-2026)
    Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 7. Pfizer Major Business
    Table 8. Pfizer Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 9. Pfizer Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Yangtze River Corporate Information, Head Office, and Major Competitors
    Table 11. Yangtze River Major Business
    Table 12. Yangtze River Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 13. Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Torrent Pharma Corporate Information, Head Office, and Major Competitors
    Table 15. Torrent Pharma Major Business
    Table 16. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 17. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. J&J Corporate Information, Head Office, and Major Competitors
    Table 19. J&J Major Business
    Table 20. J&J Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 21. J&J Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Chengdu Brilliant Corporate Information, Head Office, and Major Competitors
    Table 23. Chengdu Brilliant Major Business
    Table 24. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 25. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Novartis Corporate Information, Head Office, and Major Competitors
    Table 27. Novartis Major Business
    Table 28. Novartis Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 29. Novartis Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Qilu Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 31. Qilu Pharmaceutical Major Business
    Table 32. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 33. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Xiuzheng Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 35. Xiuzheng Pharmaceutical Major Business
    Table 36. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 37. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Hubei Hengan Corporate Information, Head Office, and Major Competitors
    Table 39. Hubei Hengan Major Business
    Table 40. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 41. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. TARO Corporate Information, Head Office, and Major Competitors
    Table 43. TARO Major Business
    Table 44. TARO Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 45. TARO Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Perrigo Corporate Information, Head Office, and Major Competitors
    Table 47. Perrigo Major Business
    Table 48. Perrigo Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 49. Perrigo Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Galderma pharm Corporate Information, Head Office, and Major Competitors
    Table 51. Galderma pharm Major Business
    Table 52. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 53. Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Zhejiang Deyer Corporate Information, Head Office, and Major Competitors
    Table 55. Zhejiang Deyer Major Business
    Table 56. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 57. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Valeant Pharma Corporate Information, Head Office, and Major Competitors
    Table 59. Valeant Pharma Major Business
    Table 60. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 61. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Moberg Corporate Information, Head Office, and Major Competitors
    Table 63. Moberg Major Business
    Table 64. Moberg Onychomycosis (Tinea Unguium) Drug Product and Solutions
    Table 65. Moberg Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. Global Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) by Players (2019-2021)
    Table 67. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players (2019-2021)
    Table 68. Breakdown of Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 69. Onychomycosis (Tinea Unguium) Drug Players Head Office, Products and Services Provided
    Table 70. Onychomycosis (Tinea Unguium) Drug Mergers & Acquisitions in the Past Five Years
    Table 71. Onychomycosis (Tinea Unguium) Drug New Entrants and Expansion Plans
    Table 72. Global Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) by Type (2016-2021)
    Table 73. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2016-2021)
    Table 74. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Type (2021-2026)
    Table 75. Global Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021)
    Table 76. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Application (2021-2026)
    Table 77. North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 78. North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 79. North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 80. North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 81. North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 82. North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2021-2026) & (USD Million)
    Table 83. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 84. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 85. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 86. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 87. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 88. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 91. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 92. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 93. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & (USD Million)
    Table 94. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2021-2026) & (USD Million)
    Table 95. South America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 96. South America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 97. South America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 98. South America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 99. South America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 100. South America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 103. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 104. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 105. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 106. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Onychomycosis (Tinea Unguium) Drug Picture
    Figure 2. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type in 2020
    Figure 3. Oral Medication
    Figure 4. External Medicine
    Figure 5. Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application in 2020
    Figure 6. Age under 18 Picture
    Figure 7. Age 18-50 Picture
    Figure 8. Age above 50 Picture
    Figure 9. Global Onychomycosis (Tinea Unguium) Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Onychomycosis (Tinea Unguium) Drug Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2026)
    Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in 2020
    Figure 13. North America Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Onychomycosis (Tinea Unguium) Drug Market Drivers
    Figure 19. Onychomycosis (Tinea Unguium) Drug Market Restraints
    Figure 20. Onychomycosis (Tinea Unguium) Drug Market Trends
    Figure 21. Pfizer Recent Developments and Future Plans
    Figure 22. Yangtze River Recent Developments and Future Plans
    Figure 23. Torrent Pharma Recent Developments and Future Plans
    Figure 24. J&J Recent Developments and Future Plans
    Figure 25. Chengdu Brilliant Recent Developments and Future Plans
    Figure 26. Novartis Recent Developments and Future Plans
    Figure 27. Qilu Pharmaceutical Recent Developments and Future Plans
    Figure 28. Xiuzheng Pharmaceutical Recent Developments and Future Plans
    Figure 29. Hubei Hengan Recent Developments and Future Plans
    Figure 30. TARO Recent Developments and Future Plans
    Figure 31. Perrigo Recent Developments and Future Plans
    Figure 32. Galderma pharm Recent Developments and Future Plans
    Figure 33. Zhejiang Deyer Recent Developments and Future Plans
    Figure 34. Valeant Pharma Recent Developments and Future Plans
    Figure 35. Moberg Recent Developments and Future Plans
    Figure 36. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players in 2020
    Figure 37. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 38. Global Top 3 Players Onychomycosis (Tinea Unguium) Drug Revenue Market Share in 2020
    Figure 39. Global Top 10 Players Onychomycosis (Tinea Unguium) Drug Revenue Market Share in 2020
    Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 41. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type in 2020
    Figure 42. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2021-2026)
    Figure 43. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application in 2020
    Figure 44. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2021-2026)
    Figure 45. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2026)
    Figure 46. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2026)
    Figure 47. North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2026)
    Figure 48. United States Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Canada Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2026)
    Figure 52. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2026)
    Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2026)
    Figure 54. Germany Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. France Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Russia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Italy Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2026)
    Figure 60. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2026)
    Figure 61. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2026)
    Figure 62. China Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Japan Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South Korea Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. India Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Australia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2026)
    Figure 69. South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2026)
    Figure 70. South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2026)
    Figure 71. Brazil Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Argentina Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2026)
    Figure 74. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2026)
    Figure 75. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2026)
    Figure 76. Turkey Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. UAE Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg

Related Reports

Global Onychomycosis (Tinea Unguium) Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Onychomycosis (Tinea Unguium) Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 26 Jan 2021

date Pharma & Healthcare

The Onychomycosis (Tinea Unguium) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Onychomycosis (Tinea Unguium) Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Onychomycosis (Tinea Unguium) Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

Product Tags

onychomycosis tinea unguium drug

Onychomycosis (Tinea Unguium) Drug

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>